| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2876226 | The Annals of Thoracic Surgery | 2014 | 5 Pages |
Abstract
This large data set confirms that although MPM is less common in women, they present with similar stage and are offered similar treatment options compared with men. Nevertheless, survival is far better in women compared with men, independent of confounders such as age, stage, and treatment. Differences in asbestos exposure, tumor biology, and the impact of circulating hormones on host response must be investigated to understand this survival advantage and improve prognosis for patients of both genders.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Emanuela MD, PhD, Andrea S. MD, MPH, Marlene ScD, MPH, Raja M. MD,